View All Documents & Correspondence
Compositions And Methods For The Treatment Of Multiple Sclerosis
Abstract: The invention relates to the compounds of formula II or their pharmaceutical acceptable salts as well as polymorphs solvates enantiomers stereoisomers and hydrates thereof. The invention further relates to pharmaceutical compositions comprising an effective amount of compounds of formula II and methods for treating or preventing multiple sclerosis. The compositions may be formulated for oral buccal rectal topical transdermal transmucosal intravenous or parenteral administration as a syrup or for injection. Such compositions may be used in the treatment of neurodegenerative diseases and other inflammatory diseases.
Notices, Deadlines & Correspondence
Patent Information
Applicants
CELLIX BIO PRIVATE LIMITED
Inventors
1. KANDULA, Mahesh
Specification
administering the compound of Formula II to patient suffering from at least one of a neurodegenerative disease, an immune mediated disease and an inflammatory disease.
9. The pharmaceutical composition of claim 8, which is formulated to treat the underlying etiology with an effective amount administering the patient in need by oral administration, delayed release, patch, pad, sustained release, transmucosal, syrup, topical, parenteral administration, injection, subdermal, oral solution, rectal administration, buccal administration or transdermal administration.
10. Compounds and compositions of claim 9 are formulated for the treatment ofmultiple sclerosis, psoriasis and inflammatory diseases.
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | Form 5 [25-04-2017(online)].pdf | 2017-04-25 |
| 2 | Form 3 [25-04-2017(online)].pdf | 2017-04-25 |
| 3 | Form 20 [25-04-2017(online)].pdf | 2017-04-25 |
| 4 | Form 1 [25-04-2017(online)].pdf | 2017-04-25 |
| 5 | Drawing [25-04-2017(online)].pdf | 2017-04-25 |
| 6 | Description(Complete) [25-04-2017(online)].pdf_69.pdf | 2017-04-25 |
| 7 | Description(Complete) [25-04-2017(online)].pdf | 2017-04-25 |
| 8 | 201747014702.pdf | 2017-04-26 |
| 9 | 201747014702-FORM-26 [20-07-2017(online)].pdf | 2017-07-20 |
| 10 | Correspondence by Agent_Power of Attorney_27-07-2017.pdf | 2017-07-27 |
| 11 | abstract 201747014702 .jpg | 2017-07-31 |
| 12 | 201747014702-Proof of Right (MANDATORY) [18-10-2017(online)].pdf | 2017-10-18 |
| 13 | 201747014702-FORM 3 [25-10-2017(online)].pdf | 2017-10-25 |
| 14 | 201747014702-FORM 18 [27-09-2018(online)].pdf | 2018-09-27 |
| 15 | 201747014702-RELEVANT DOCUMENTS [30-10-2018(online)].pdf | 2018-10-30 |
| 16 | 201747014702-FORM 13 [30-10-2018(online)].pdf | 2018-10-30 |
| 17 | Correspondence by Agent_Power Of Attorney_01-11-2018.pdf | 2018-11-01 |
| 18 | 201747014702-FORM 3 [08-01-2019(online)].pdf | 2019-01-08 |
| 19 | 201747014702-FER.pdf | 2019-09-06 |
| 20 | 201747014702-OTHERS [27-02-2020(online)].pdf | 2020-02-27 |
| 21 | 201747014702-FORM 3 [27-02-2020(online)].pdf | 2020-02-27 |
| 22 | 201747014702-FER_SER_REPLY [27-02-2020(online)].pdf | 2020-02-27 |
| 23 | 201747014702-DRAWING [27-02-2020(online)].pdf | 2020-02-27 |
| 24 | 201747014702-CORRESPONDENCE [27-02-2020(online)].pdf | 2020-02-27 |
| 25 | 201747014702-COMPLETE SPECIFICATION [27-02-2020(online)].pdf | 2020-02-27 |
| 26 | 201747014702-CLAIMS [27-02-2020(online)].pdf | 2020-02-27 |
| 27 | 201747014702-Annexure [27-02-2020(online)].pdf | 2020-02-27 |
| 28 | 201747014702-ABSTRACT [27-02-2020(online)].pdf | 2020-02-27 |
| 29 | 201747014702-US(14)-HearingNotice-(HearingDate-18-08-2020).pdf | 2020-07-13 |
| 30 | 201747014702-FORM-26 [14-08-2020(online)].pdf | 2020-08-14 |
| 31 | 201747014702-Correspondence to notify the Controller [14-08-2020(online)].pdf | 2020-08-14 |
| 32 | 201747014702-Written submissions and relevant documents [26-08-2020(online)].pdf | 2020-08-26 |
| 33 | 201747014702-FORM 3 [26-08-2020(online)].pdf | 2020-08-26 |
| 34 | 201747014702-Annexure [26-08-2020(online)].pdf | 2020-08-26 |
| 35 | 201747014702-PatentCertificate09-09-2020.pdf | 2020-09-09 |
| 36 | 201747014702-Marked up Claims_Granted 346383_09-09-2020.pdf | 2020-09-09 |
| 37 | 201747014702-IntimationOfGrant09-09-2020.pdf | 2020-09-09 |
| 38 | 201747014702-Drawings_Granted 346383_09-09-2020.pdf | 2020-09-09 |
| 39 | 201747014702-Description_Granted 346383_09-09-2020.pdf | 2020-09-09 |
| 40 | 201747014702-Claims_Granted 346383_09-09-2020.pdf | 2020-09-09 |
| 41 | 201747014702-Abstract_Granted 346383_09-09-2020.pdf | 2020-09-09 |
| 42 | 201747014702-FORM FOR STARTUP [23-09-2020(online)].pdf | 2020-09-23 |
| 43 | 201747014702-EVIDENCE FOR REGISTRATION UNDER SSI [23-09-2020(online)].pdf | 2020-09-23 |
| 44 | 201747014702-RELEVANT DOCUMENTS [06-05-2022(online)].pdf | 2022-05-06 |
| 45 | 201747014702-RELEVANT DOCUMENTS [29-08-2022(online)].pdf | 2022-08-29 |
Search Strategy
| 1 | Searchstrategy_28-08-2019.pdf |